{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:44:43Z","timestamp":1773168283492,"version":"3.50.1"},"reference-count":94,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Coronavirus infectious disease-19 (COVID-19) is a pandemic characterized by serious lung disease and thrombotic events in the venous and circulation trees, which represent a harmful clinical sign of poor outcome. Thrombotic events are more frequent in patients with severe disease requiring intensive care units and are associated with platelet and clotting activation. However, after resolution of acute infection, patients may still have clinical sequelae, the so-called long-COVID-19, including thrombotic events again in the venous and arterial circulation. The mechanisms accounting for thrombosis in acute and long COVID-19 have not been fully clarified; interactions of COVID-19 with angiotensin converting enzyme 2 or toll-like receptor family or infection-induced cytokine storm have been suggested to be implicated in endothelial cells, leucocytes, and platelets to elicit clotting activation in acute as well in chronic phase of the disease. In acute COVID-19, prophylactic or full doses of anticoagulants exert beneficial effects even if the dosage choice is still under investigation; however, a residual risk still remains suggesting a need for a more appropriate therapeutic approach. In long COVID-19 preliminary data provided useful information in terms of antiplatelet treatment but definition of candidates for thrombotic prophylaxis is still undefined.<\/jats:p>","DOI":"10.1055\/s-0043-1776713","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:47:50Z","timestamp":1700095670000},"page":"286-296","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics"],"prefix":"10.1055","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-7068","authenticated-orcid":false,"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[{"name":"Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy"},{"name":"Mediterranea Cardiocentro, Via Orazio, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job","family":"Harenberg","sequence":"additional","affiliation":[{"name":"Medical Faculty Mannheim, Ruprecht\u2013karls University Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy"},{"name":"Mediterranea Cardiocentro, Via Orazio, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Cammisotto","sequence":"additional","affiliation":[{"name":"Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"W J Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"G Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"L Zhang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"J B Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/cid\/cix164","article-title":"Cardiovascular complications and short-term mortality risk in community-acquired pneumonia","volume":"64","author":"F Violi","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2015.05.028","article-title":"Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events","volume":"116","author":"R Cangemi","year":"2015","journal-title":"Am J Cardiol"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"V F Corrales-Medina","year":"2015","journal-title":"JAMA"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/a-1692-9939","article-title":"Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicenter observational study","volume":"122","author":"R Cangemi","year":"2022","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1473-3099(21)00211-5","article-title":"Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study","volume":"21","author":"L C Lund","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/joim.13241","article-title":"Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19","volume":"290","author":"I Yeo","year":"2021","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","article-title":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study","volume":"377","author":"I Katsoularis","year":"2022","journal-title":"BMJ"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Y Xie","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.122.060785","article-title":"Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales","volume":"146","author":"R Knight","year":"2022","journal-title":"Circulation"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/cvr\/cvac195","article-title":"Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank","volume":"119","author":"E YF Wan","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1055\/a-1788-7592","article-title":"The ADA (Age-D-Dimer-Albumin) score to predict thrombosis in SARS-CoV-2","volume":"122","author":"F Violi","year":"2022","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"M Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series","volume":"396","author":"B T Bradley","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"P C Evans","year":"2020","journal-title":"Cardiovasc Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Z Varga","year":"2020","journal-title":"Lancet"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"P Canzano","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"S Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","article-title":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells","volume":"143","author":"I R McCracken","year":"2021","journal-title":"Circulation"},{"issue":"09","key":"ref24","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00134-020-06147-7","article-title":"Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection","volume":"46","author":"N Cardot-Leccia","year":"2020","journal-title":"Intensive Care Med"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"D J Green","year":"2011","journal-title":"Hypertension"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"106975","DOI":"10.1016\/j.vph.2022.106975","article-title":"Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study","volume":"144","author":"E Oikonomou","year":"2022","journal-title":"Vascul Pharmacol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/09537104.2021.1962519","article-title":"Alterations in platelets during SARS-CoV-2 infection","volume":"33","author":"M Brambilla","year":"2022","journal-title":"Platelets"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCRESAHA.120.318218","article-title":"Platelets and COVID-19: inflammation, hyperactivation and additional questions","volume":"127","author":"M Koupenova","year":"2020","journal-title":"Circ Res"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"B K Manne","year":"2020","journal-title":"Blood"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"A Choudhury","year":"2020","journal-title":"J Med Virol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/ATVBAHA.116.308351","article-title":"NADPH Oxidase-2 and Atherothrombosis: insight from chronic granulomatous disease","volume":"37","author":"F Violi","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"M Koupenova","year":"2019","journal-title":"Nat Commun"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"e00348","DOI":"10.14309\/ctg.0000000000000348","article-title":"Low-grade endotoxemia and thrombosis in COVID-19","volume":"12","author":"A Oliva","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.122.321541","article-title":"Toll-like receptor 4-dependent platelet-related thrombosis in SARS-CoV-2 infection","volume":"132","author":"R Carnevale","year":"2023","journal-title":"Circ Res"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Y Nadir","year":"2010","journal-title":"Haematologica"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u03b1 and cathepsin G","volume":"38","author":"E J Folco","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5663","key":"ref37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"V Brinkmann","year":"2004","journal-title":"Science"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"P Li","year":"2010","journal-title":"J Exp Med"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"P Skendros","year":"2020","journal-title":"J Clin Invest"},{"issue":"40","key":"ref40","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"J C Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"742446","DOI":"10.3389\/fimmu.2021.742446","article-title":"Complement alternative and mannose-binding lectin pathway activation is associated with COVID-19 mortality","volume":"12","author":"F Defendi","year":"2021","journal-title":"Front Immunol"},{"issue":"59","key":"ref42","doi-asserted-by":"crossref","first-page":"eabh2259","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"L Ma","year":"2021","journal-title":"Sci Immunol"},{"issue":"7836","key":"ref43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"J Carvelli","year":"2020","journal-title":"Nature"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"M Cugno","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","article-title":"Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes","volume":"223","author":"A H de Nooijer","year":"2021","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"C Magro","year":"2020","journal-title":"Transl Res"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Z Swank","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"C Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"848886","DOI":"10.3389\/fimmu.2022.848886","article-title":"Persistent overactive cytotoxic immune response in a spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers","volume":"13","author":"M Gal\u00e1n","year":"2022","journal-title":"Front Immunol"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-022-01579-5","article-title":"Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC)","volume":"21","author":"E Pretorius","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"e1247","DOI":"10.1016\/S2214-109X(22)00286-8","article-title":"Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study","volume":"10","author":"M Dryden","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1038\/s41467-021-26884-7","article-title":"Organ-specific genome diversity of replication-competent SARS-CoV-2","volume":"12","author":"J Van Cleemput","year":"2021","journal-title":"Nat Commun"},{"issue":"7851","key":"ref53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"C Gaebler","year":"2021","journal-title":"Nature"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvac115","article-title":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases","volume":"119","author":"M Gy\u00f6ngy\u00f6si","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: a systematic review and meta-analysis","volume":"11","author":"S Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis","volume":"101","author":"F Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"14","key":"ref57","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.3390\/ijms21145168","article-title":"Covid-19: the rollercoaster of Fibrin(Ogen), D-dimer, von Willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes","volume":"21","author":"C Grobler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"714426","DOI":"10.3389\/fmed.2021.714426","article-title":"Serum metabolic profile in patients with long-Covid (PASC) syndrome: clinical implications","volume":"8","author":"E Pasini","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.47102\/annals-acadmedsg.202175","article-title":"ST-segment elevation myocardial infarction in post-COVID-19 patients: a case series","volume":"50","author":"S W Wong","year":"2021","journal-title":"Ann Acad Med Singap"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jth.15267","article-title":"Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response","volume":"19","author":"L Townsend","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.26575","article-title":"Hypercoagulability, endotheliopathy, and inflammation approximating 1\u2009year after recovery: assessing the long-term outcomes in COVID-19 patients","volume":"97","author":"B E Fan","year":"2022","journal-title":"Am J Hematol"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/jth.15490","article-title":"Persistent endotheliopathy in the pathogenesis of long COVID syndrome","volume":"19","author":"H Fogarty","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12933-022-01623-4","article-title":"Proteomics of fibrin amyloid microclots in long COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system","volume":"21","author":"A Kruger","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2021.10.140","article-title":"In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19","volume":"345","author":"H Mejia-Renteria","year":"2021","journal-title":"Int J Cardiol"},{"issue":"07","key":"ref65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1113\/EP089481","article-title":"Carotid stiffness, intima-media thickness and aortic augmentation index among adults with SARS-CoV-2","volume":"107","author":"R E Szeghy","year":"2022","journal-title":"Exp Physiol"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.mayocp.2021.06.027","article-title":"Viral endothelial dysfunction: a unifying mechanism for COVID-19","volume":"96","author":"M Prasad","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/jcm12041413","article-title":"Vascular function, systemic inflammation, and coagulation activation 18 months after COVID-19 infection: an observational cohort study","volume":"12","author":"L H Willems","year":"2023","journal-title":"J Clin Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","article-title":"NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond","volume":"13","author":"Y Zhu","year":"2022","journal-title":"Front Immunol"},{"issue":"09","key":"ref69","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.jtha.2023.02.033","article-title":"NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel","volume":"21","author":"N Krinsky","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0040-1721778","article-title":"Waves of SARS-CoV-2 infection and blood coagulation-a link and beyond","volume":"121","author":"J Harenberg","year":"2021","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1055\/s-0040-1716543","article-title":"The multiple faces of heparin: opportunities in COVID-19 infection and beyond","volume":"120","author":"L Drouet","year":"2020","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref72","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"A C Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref73","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"A Cuker","year":"2021","journal-title":"Blood Adv"},{"issue":"08","key":"ref74","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3324\/haematol.2022.280652","article-title":"Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis","volume":"107","author":"L Loffredo","year":"2022","journal-title":"Haematologica"},{"issue":"14","key":"ref75","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s40265-020-01365-1","article-title":"Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19?","volume":"80","author":"V Bianconi","year":"2020","journal-title":"Drugs"},{"issue":"07","key":"ref76","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1055\/a-1477-3569","article-title":"Anticoagulant treatment of COVID-19 as early as possible-sulodexide and perspectives","volume":"121","author":"S Schulman","year":"2021","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/jcm12052038","article-title":"COVID-19 and the response to antiplatelet therapy","volume":"12","author":"T Bolek","year":"2023","journal-title":"J Clin Med"},{"issue":"33","key":"ref78","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz893","article-title":"Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction","volume":"41","author":"R Carnevale","year":"2020","journal-title":"Eur Heart J"},{"issue":"05","key":"ref79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/M22-3428","article-title":"Safety and efficacy of combination SARS-CoV-2 neutralizing monoclonal antibodies amubarvimab plus romlusevimab in nonhospitalized patients with COVID-19","volume":"176","author":"T H Evering","year":"2023","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1317","article-title":"Serum albumin is inversely associated with portal vein thrombosis in cirrhosis","volume":"3","author":"S Basili","year":"2019","journal-title":"Hepatol Commun"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/ars.2020.8142","article-title":"Is albumin predictor of mortality in COVID-19?","volume":"35","author":"F Violi","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"03","key":"ref82","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.120.317173","article-title":"Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19","volume":"127","author":"F Violi","year":"2020","journal-title":"Circ Res"},{"issue":"02","key":"ref83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-022-02757-8","article-title":"External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX trial","volume":"55","author":"G Chi","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0040-1721486","article-title":"Albumin supplementation dampens hypercoagulability in COVID-19: a preliminary report","volume":"121","author":"F Violi","year":"2021","journal-title":"Thromb Haemost"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"108555","DOI":"10.1016\/j.clim.2020.108555","article-title":"Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19","volume":"219","author":"J Laurence","year":"2020","journal-title":"Clin Immunol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2020.00857","article-title":"Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study","volume":"11","author":"V Giudice","year":"2020","journal-title":"Front Pharmacol"},{"issue":"07","key":"ref87","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"F Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"09","key":"ref88","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.202007-2778LE","article-title":"Complement inhibition with the C5 blocker LFG316 in severe COVID-19","volume":"202","author":"W M Zelek","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref89","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"A PJ Vlaar","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy","volume":"220","author":"D C Mastellos","year":"2020","journal-title":"Clin Immunol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"S Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/a-1956-9641","article-title":"Knowledge gaps for prophylactic use of antithrombotic agents in patients with COVID-19: insights into new SARS-CoV-2 variants, vaccination status, and emerging oral antivirals","volume":"123","author":"A H Talasaz","year":"2023","journal-title":"Thromb Haemost"},{"issue":"13","key":"ref93","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"327","author":"C A Bradbury","year":"2022","journal-title":"JAMA"},{"issue":"09","key":"ref94","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"P R Lawler","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1776713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:56:16Z","timestamp":1730807776000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1776713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":94,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,3,26]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1776713","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]}}}